By: ICN Bureau
Last updated : October 16, 2025 8:38 am
Sourced and formulated in the United States, Ameriflor Calm is derived from plants grown on regenerative organic certified farms and is manufactured at a site that uses 100% renewable electricity
BASF's Personal Care business has launched Ameriflor Calm, a botanical active ingredient designed to strengthen sensitive skin's natural resilience. Sourced from the Self-Heal plant (Prunella vulgaris), it helps reduce redness, minimize trans-epidermal water loss, and defend against environmental stressors.
This innovative product not only helps to reduce redness appearance and trans-epidermal water loss but also defends against environmental aggressors. Sourced from regenerative organic certified farms in Oregon by the Regenerative Organic Alliance and produced in the United States at a manufacturing site that runs on 100% renewable electricity, Ameriflor Calm exemplifies BASF’s commitment to sustainability and ethical practices.
“In today’s market where consumers value transparency and efficiency, Ameriflor Calm reduces the appearance of redness, supports skin barrier function, and strengthens resistance to environmental stressors, seamlessly blending the plant-based knowledge from Indigenous traditions in the Americas with modern scientific techniques to enhance the resilience of sensitive skin,” says Lucilene Veira-Nunes, Global Business Management, Beauty Care Solutions at BASF.
“Ameriflor Calm addresses the pervasive issue of sensitive skin by combining modern science with bioactive compounds from the Self-Heal plant (Prunella vulgaris), a resilient botanical that has long been utilized in traditional practices by Indigenous nations such as the Nitassinan, Catawba, Cherokee and the Algonquin-speaking nations.”3
Ameriflor Calm was tested in clinical studies with participants showing signs of sensitive skin, applied at 1% concentration over 28 days, with evaluations at baseline, 7 days, and 28 days. After 7 days of use, the ingredient demonstrated a 10% improvement in skin redness appearance and showed a significant improvement compared to the placebo (8%), with continued positive results observed after 28 days of use. Trans-epidermal water loss also improved substantially by 11% compared to placebo after 7 days of use.